[250 Pages Report] Collagen hydrolysates market size exceeded USD 1.1 Bn in 2022 and is estimated to grow at over 7.5% CAGR between 2022 and 2032. The North American collagen hydrolysates market is expected to register a 7.2% CAGR between 2022 and 2032. In 2027, the hydrolyzed collagen market is expected to develop a year-on-year growth rate of 8.3%.
| Attribute | Details |
|---|---|
| Collagen Hydrolysates Market Size (2022E) | USD 1.1 Billion |
| Collagen Hydrolysates Market Projected Size (2032F) | USD 1.9 Billion |
| Value CAGR (2022-2032) | 7.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The need for innovative food and beverage products is growing all around the world. Collagen that has been fully hydrolyzed is soluble in both cold and hot water. Hydrolyzed collagen is simple to incorporate into food and beverage items. It is a natural protein that can be used in food and beverage products which is promoting the hydrolyzed collagen market globally.
Nowadays, food and beverage makers are emphasizing the inclusion of nutritious and healthful components in their goods in order to meet consumers' nutritional needs and thus earn customer appeal.
Consumers are increasingly concerned about their health and are lowering their use of products with high levels of fat, calories, and sodium. As hydrolyzed collagen contains a large number of proteins and aids in the prevention of a variety of diseases, demand for it is skyrocketing in various parts of the world.
Hydrolyzed collagen is a pure protein form that is easily digestive and highly bioavailable for a balanced diet. It is a safe product to use as a health supplement because it includes no hormones, chemicals, or antibiotics. Consumers who are health-conscious are looking for natural sources of protein to help fill in the gaps in their diets for specific nutrients that are required for the body to function properly.
The health benefits it delivers, such as repairing a leaky gut, supporting weight management, protecting the heart, supporting bone repair, improving liver function, preventing joint discomfort, and many more, are all likely to increase demand for a healthy balanced lifestyle in the coming years. As a result, demand for hydrolyzed collagen is expected to rise in the future.
Principal Consultant
The rising demand for ready-to-eat collagen products can be ascribed to the growing population of working women and changing lifestyles. Hydrolyzed collagen supplements are currently being used for post-surgery recovery, cardiovascular treatments, burn and wound care, and dentistry applications. It is gaining market share in the US market as its applications in the treatment of patients with specific digestive, amino acid metabolism issues expand, and absorption.
According to FMI, the collagen hydrolysates market is experiencing growth in the German market due to its high application in the cosmetic industry.
Collagen cosmetic supplements improve skin firmness and elasticity by restoring suppleness and reducing flaking, which helps to prevent wrinkles. Face creams, face masks, serums, and a variety of other beauty products have seen an increase in demand for hydrolyzed collagen.
Due to its antioxidant foaming and emulsifying properties, hydrolyzed collagen is utilized as a natural component in cosmetic products. Skin Care is one of the most common collagen applications because it is used in makeup kits, soaps, and serums to improve the appearance of dry or damaged skin by reducing flaking and replenishing nutrients.
Changing lifestyles, eating habits, the adoption of western eating habits, an increase in demand for functional additives in food items, and The growth of the collagen market in India has been aided by a rise in industrial activity that necessitates process improvement.
Due to its high processing yields, low cost compared to marine collagen, and Halal/Kosher certification, bovine collagen is widely used in the culinary, cosmetic, and pharmaceutical industries.
By enhancing the quality and amount of skin collagen, bovine collagen improves the quality of withering and aging skin. It has also been shown to alleviate the symptoms of osteoporosis, a disorder in which bone density deteriorates.
Apart from that, the usage of bovine hydrolyzed collagen as a food additive in cakes, sweets, and other food products is further driving market expansion. Increased demand for collagen peptides as prospective oral supplements to help recover osteoarticular tissues would open up attractive economic opportunities for the sector.
The powder form of hydrolyzed collagen had the largest proportion of the hydrolyzed collagen market. This is because hydrolyzed collagen powder is easily digested and absorbed by the human body. It is very adaptable and flavorless, so it can be used in tea, coffee, water, cuisine, and other foods and beverages. As a result, it is more popular than other types of hydrolyzed collagen on the market.
The global hydrolyzed collagen market was led by the health and nutrition category. This is owing to consumers' changing lifestyles and unsuitable eating habits, which has resulted in a large demand for dietary supplements in the market that may deliver important in order to improve or maintain health. As a result, the nutraceuticals industry has placed a high demand on hydrolyzed collagen.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In order to extend their product range and meet expanding product demand across countries, companies are launching new products, forming alliances, and innovating. Manufacturers use new product releases with quality certifications to reach clients all around the world.
For Example,
Tendoforte, Gelita's novel bioactive collagen peptide, was developed in 2018 with the goal of strengthening tendons and ligaments and reducing injuries in both amateur and professional athletes. The company intends to grow sales as a sports supplement and expand its market share in the worldwide market with the introduction of this clean label ingredient.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | USD Billion for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; and MEA |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Nordic, Russia, Poland, China, India, Japan, ASEAN, Australia, New Zealand, GCC Countries, South Africa, North Africa, others |
| Key Segments Covered | Source, Dosage Form, Application, and Region |
| Key Companies Profiled | Inc. Amicogen; PB Gelatins GmbH; Beijing Semnl Biotechnology Co, Ltd.; NeoCell Corporation; Nitta Gelatin, Inc.; Rousselot; Connoils LLC; Amicogen, Inc.; Essen Nutrition; Foodmate Co., Ltd.; Others |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The collagen hydrolysates market will reach nearly USD 1.1 Bn by 2022.
The collagen hydrolysates market is growing at a CAGR of 7.5% in 2022 and is expected to reach a market value of USD 1.9 Bn in 2032.
The North American collagen hydrolysates market is expected to register a 7.2% CAGR between 2022 and 2032.
The demand for collagen hydrolysates in Europe is expected to grow at 8.7% CAGR between 2022 and 2032.
Growing consumer concern and understanding about healthy food products around the world will drive product growth. Collagen hydrolysates are also being used more widely in dermal surgery treatments to repair wrinkles, depressions, and skin scarring issues, which is helping to grow the market for collagen hydrolysates.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Product launches & Recent Developments 3.4. Product Life Cycle Analysis 3.5. Value Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. % of Operating Margin Analysis 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Global Market- Pricing Analysis 3.6.1. Price Point Assessment by Region 3.6.2. Price Point Assessment by Source 3.6.3. Price Forecast till 2032 3.6.4. Factors affecting Pricing 3.7. Forecast Factors - Relevance & Impact 3.8. Regulatory Landscape 3.8.1. Packaging & Labelling Regulations 3.8.2. Certifications and Certifying Agency Overview 3.8.3. Import/Export Policies 3.9. Regional Parent Market Outlook 3.10. Consumers Survey Analysis 3.11. Macro-Economic Factors 3.12. Product Claims & Nutritional Information Scan by Buyers 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (MT) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Source 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Source, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Source, 2022-2032 5.3.1. Bovine 5.3.2. Marine 5.3.3. Porcine 5.4. Y-o-Y Growth Trend Analysis By Source, 2017-2021 5.5. Absolute $ Opportunity Analysis By Source, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Dosage Form, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Dosage Form, 2022-2032 6.3.1. Liquid 6.3.2. Powder 6.3.3. Capsules 6.4. Y-o-Y Growth Trend Analysis By Dosage Form, 2017-2021 6.5. Absolute $ Opportunity Analysis By Dosage Form, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Application, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Application, 2022-2032 7.3.1. Food and Beverages 7.3.2. Pharmaceutical 7.3.3. Cosmetics 7.3.4. Nutraceuticals 7.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 7.5. Absolute $ Opportunity Analysis By Application, 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Source 9.2.3. By Dosage Form 9.2.4. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Source 9.3.3. By Dosage Form 9.3.4. By Application 9.4. Key Takeaways 10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Chile 10.2.1.5. Peru 10.2.1.6. Rest of Latin America 10.2.2. By Source 10.2.3. By Dosage Form 10.2.4. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Source 10.3.3. By Dosage Form 10.3.4. By Application 10.4. Key Takeaways 11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Poland 11.2.1.9. Nordic Countries 11.2.1.10. Rest of Europe 11.2.2. By Source 11.2.3. By Dosage Form 11.2.4. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Source 11.3.3. By Dosage Form 11.3.4. By Application 11.4. Key Takeaways 12. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Source 12.2.3. By Dosage Form 12.2.4. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Source 12.3.3. By Dosage Form 12.3.4. By Application 12.4. Key Takeaways 13. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Thailand 13.2.1.3. Malaysia 13.2.1.4. Indonesia 13.2.1.5. Rest of South Asia 13.2.2. By Source 13.2.3. By Dosage Form 13.2.4. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Source 13.3.3. By Dosage Form 13.3.4. By Application 13.4. Key Takeaways 14. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Source 14.2.3. By Dosage Form 14.2.4. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Source 14.3.3. By Dosage Form 14.3.4. By Application 14.4. Key Takeaways 15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Central Africa 15.2.1.4. North Africa 15.2.2. By Source 15.2.3. By Dosage Form 15.2.4. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Source 15.3.3. By Dosage Form 15.3.4. By Application 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Source 16.1.2.2. By Dosage Form 16.1.2.3. By Application 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Source 16.2.2.2. By Dosage Form 16.2.2.3. By Application 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Source 16.3.2.2. By Dosage Form 16.3.2.3. By Application 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Source 16.4.2.2. By Dosage Form 16.4.2.3. By Application 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Source 16.5.2.2. By Dosage Form 16.5.2.3. By Application 16.6. Chile 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Source 16.6.2.2. By Dosage Form 16.6.2.3. By Application 16.7. Peru 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Source 16.7.2.2. By Dosage Form 16.7.2.3. By Application 16.8. Germany 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Source 16.8.2.2. By Dosage Form 16.8.2.3. By Application 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Source 16.9.2.2. By Dosage Form 16.9.2.3. By Application 16.10. France 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Source 16.10.2.2. By Dosage Form 16.10.2.3. By Application 16.11. Spain 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Source 16.11.2.2. By Dosage Form 16.11.2.3. By Application 16.12. U.K. 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Source 16.12.2.2. By Dosage Form 16.12.2.3. By Application 16.13. Russia 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Source 16.13.2.2. By Dosage Form 16.13.2.3. By Application 16.14. Poland 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Source 16.14.2.2. By Dosage Form 16.14.2.3. By Application 16.15. BENELUX 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Source 16.15.2.2. By Dosage Form 16.15.2.3. By Application 16.16. Nordic Countries 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Source 16.16.2.2. By Dosage Form 16.16.2.3. By Application 16.17. China 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Source 16.17.2.2. By Dosage Form 16.17.2.3. By Application 16.18. Japan 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Source 16.18.2.2. By Dosage Form 16.18.2.3. By Application 16.19. South Korea 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Source 16.19.2.2. By Dosage Form 16.19.2.3. By Application 16.20. India 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Source 16.20.2.2. By Dosage Form 16.20.2.3. By Application 16.21. Thailand 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Source 16.21.2.2. By Dosage Form 16.21.2.3. By Application 16.22. Indonesia 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2021 16.22.2.1. By Source 16.22.2.2. By Dosage Form 16.22.2.3. By Application 16.23. Malaysia 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2021 16.23.2.1. By Source 16.23.2.2. By Dosage Form 16.23.2.3. By Application 16.24. Singapore 16.24.1. Pricing Analysis 16.24.2. Market Share Analysis, 2021 16.24.2.1. By Source 16.24.2.2. By Dosage Form 16.24.2.3. By Application 16.25. GCC Countries 16.25.1. Pricing Analysis 16.25.2. Market Share Analysis, 2021 16.25.2.1. By Source 16.25.2.2. By Dosage Form 16.25.2.3. By Application 16.26. South Africa 16.26.1. Pricing Analysis 16.26.2. Market Share Analysis, 2021 16.26.2.1. By Source 16.26.2.2. By Dosage Form 16.26.2.3. By Application 16.27. Central Africa 16.27.1. Pricing Analysis 16.27.2. Market Share Analysis, 2021 16.27.2.1. By Source 16.27.2.2. By Dosage Form 16.27.2.3. By Application 16.28. North Africa 16.28.1. Pricing Analysis 16.28.2. Market Share Analysis, 2021 16.28.2.1. By Source 16.28.2.2. By Dosage Form 16.28.2.3. By Application 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Source 17.3.3. By Dosage Form 17.3.4. By Application 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Amicogen 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. PB Gelatins GmbH 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Beijing Semnl Biotechnology Co, Ltd. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. NeoCell Corporation 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Nitta Gelatin, Inc. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Rousselot 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Connoils LLC 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Amicogen, Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Essen Nutrition 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Foodmate Co., Ltd 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Gelita AG 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. Weishardt Group 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 18.1.13. Darling Ingredients Inc 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.13.5.2. Product Strategy 18.1.13.5.3. Channel Strategy 18.1.14. Kayos 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments (Source/Dosage Form/Application/Region) 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.14.5.2. Product Strategy 18.1.14.5.3. Channel Strategy 18.1.15. Others on Additional Request 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
Collagen Hydrolysates Market
